SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-035212
Filing Date
2024-08-01
Accepted
2024-08-01 07:50:32
Documents
16
Period of Report
2024-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20033332_8k.htm   iXBRL 8-K 33807
2 EXHIBIT 10.1 ef20033332_ex10-1.htm EX-10.1 93470
3 EXHIBIT 99.1 ef20033332_ex99-1.htm EX-99.1 15473
7 image00001.jpg GRAPHIC 5266
  Complete submission text file 0001140361-24-035212.txt   316321

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA galt-20240726.xsd EX-101.SCH 3901
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20240726_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20240726_pre.xml EX-101.PRE 16068
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20033332_8k_htm.xml XML 4244
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 241164368
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)